Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
9/10
|
7.58 | 35.42 | -78.6% | 10.38 | -26.99% |
| P/S |
|
0.4071 | 7.59 | -94.63% |
|
|
| P/BV |
|
0.8382 | 3.68 | -77.25% |
|
|
| P/FCF |
|
21.03 | 55.3 | -61.97% |
|
|
| Ev/Ebitda |
|
7.92 | 2.91 | 172.36% |
|
|
| Ev/S |
|
0.5848 | 23.72 | -97.53% |
|
|
| Ev/FCF |
|
17.84 | 63.78 | -72.03% |
|
|
| E/P |
|
0.0779 | 0.0326 | 138.73% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
3/10
|
8.79 | -11.9 | -173.86% | 7.56 | +16.31% |
| ROE |
|
12.11 | 5.19 | 133.48% |
|
|
| ROA |
|
5.29 | 3.47 | 52.55% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
5.37 | -11.49 | -146.75% |
|
|
| ROCE |
|
0 | 6.04 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
6/10
|
2.09 | 0.7755 | 169.93% | 2.1 | -0.1155% |
| Nеt Debt/Ebitda |
|
0 | 0.0127 | -100% |
|
|
| Debt/Ratio |
|
0.1657 | 0.1229 | 34.86% |
|
|
| Debt/Equity |
|
1.98 | 0.802 | 147.1% |
|
|
| Debt/Net Income |
|
3.21 | 1.76 | 82.66% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
10/10
|
5.96 | 2.43 | 145.22% | 4.68 | +27.43% |
| Number of years of dividend growth |
|
7 | 1.21 | 479.31% | ||
| DSI |
|
1 | 0.563 | 77.63% |
|
|
| Average dividend growth |
|
14.29 | 3.2 | 346.24% |
|
|
| Average percentage for 5 years |
|
4.68 | 1.82 | 157.64% |
|
|
| Average percentage for payments |
|
38.68 | 23.96 | 61.44% |
|
|
| Difference from average difference in sector |
|
3.53 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
3/10
|
16.26 | 28.69 | -43.33% | ||
| Growth impulse Ebitda in 5 years |
|
55.49 | -40.52 | -236.94% | ||
| Growth impulse Net Income in 5 years |
|
27.18 | 94.84 | -71.34% | ||
| Growth impulse FCF in 5 years |
|
-5.62 | 91.41 | -106.15% | ||
| Growth impulse EPS in 5 years |
|
26.01 | -118.14 | -122.02% |
IP Score
6.22/10
